Table 3.

The demographic and clinical characteristics of patients with 90-day favourable outcome (mRS of 0–2) and unfavourable outcome (mRS of 3–6)

Variable	Favourable outcome (n = 21)	Unfavourable outcome (n = 41)	P-value
Gender (male/female)	17/4	28/13	0.375
Age (years)	51.48 ± 11.23	57.73 ± 15.67	0.109
SBP (mmHg) on admission	134.10 ± 20.69	139.73 ± 22.87	0.358
DBP (mmHg) on admission	78.05 ± 16.28	77.13 ± 15.45	0.831
Fast blood glucose (mmol/L)	6.06 ± 1.88	7.92 ± 2.41	0.003*
Heart rate (bpm)	74.38 ± 14.50	75.71 ± 17.82	0.792
BMI	22.18 ± 3.14	24.16 ± 3.03	0.019*
TG (mmol/L)	0.98 ± 0.30	1.37 ± 0.75	0.018*
CRP (mg/L)	3.70 (1.15, 7.13)	10.96 (4.57, 26.00)	0.003*
Smoker	8 (38.10)	19 (46.34)	0.596
Drinker	4 (19.05)	13 (31.71)	0.375
Hypertension	8 (38.10)	18 (43.90)	0.788
Diabetes mellitus	2 (9.52)	11 (26.83)	0.187
NIHSS on admission	9 (5, 14)	15 (11, 20)	< 0.001*
Large artery stenosis/occlusion			0.777
MCA	13 (61.90)	28 (68.29)
ICA	8 (38.10)	13 (31.71)
t-PA treatment	9 (42.86)	14 (34.15)	0.583
Onset to hospital time (min)	348.88 ± 280.57	288.33 ± 180.33	0.372
DNT (min)	115.06 ± 49.05	95.53 ± 58.58	0.258
The time intervals between completed EVT and dCA measurement (hour)	9.33 ± 3.57	7.76 ± 3.75	0.117

Values are expressed as mean ± SD or numbers (%) or median (inter- quartile range, IQR)

SBP Systolic blood pressure, DBP Diastolic blood pressure, TG Triglyceride, BMI Body Mass Index, CRP Hypersensitive C-Reactive Protein, NIHSS National Institutes of Health Stroke Scale, MCA Middle cerebral artery, ICA Internal carotid artery, DNT Door to needle time, dCA dynamic cerebral autoregulation, EVT Endovascular therapy

^*significant difference in comparing between favourable-outcome group and unfavourable-outcome group

P-value: p-value of comparing between favourable-outcome group and unfavourable-outcome group